Officially Certified: Beike Biotechnology (Qionghai) Passes Lecheng’s First Laboratory Compliance Inspection, with CellAuto’s Fully-Automated Cell Manufacturing Platform Recognised as GMP-Compliant

Editor’s note

Congratulations to Beike Biotechnology! In April 2026, the Medical Products Administration of the Boao Lecheng International Medical Tourism Pilot Zone conducted on-site compliance inspections of 17 relevant laboratories in the zone. Beike Biotechnology’s Lecheng cell-manufacturing workshop, with its solid technical system and rigorous quality management, successfully met the regulatory requirements.

The laboratory Beike passed the inspection with uses the fully-automated cell manufacturing platform deployed by CellAuto. The line strictly follows the relevant national regulations and guidelines, fully meets GMP production requirements, and has earned regulators’ high recognition for the compliance, stability and controllability of its preparation environment. On efficiency and cost, the platform uses fully-closed piping and a modular design, can be deployed in a Grade D environment, greatly reduces staffing needs, and genuinely achieves high-quality, low-cost and reproducible scaled production of cell products.

This is both a strong affirmation of Beike’s laboratory-management capability and powerful validation that CellAuto’s fully-automated cell manufacturing platform meets GMP production requirements. In future, CellAuto will continue to work with partners such as Beike, drawing on the policy advantages of the Lecheng Pilot Zone to advance the large-scale industrialisation of cell-therapy products on a safe, compliant and controllable track, helping Lecheng build a hub for innovation in new biomedical technologies.

The following is from Beike Biotechnology, Boao Lecheng Pilot Zone:

Recently, the Medical Products Administration of the Boao Lecheng International Medical Tourism Pilot Zone officially released the “Public Notice on the Results of the Compliance Inspection of Biomedical New-Technology Preparation Laboratories in the Lecheng Pilot Zone”. Following on-site assessment and review, Beike Biotechnology (Qionghai) Co., Ltd. successfully passed this compliance inspection and was recognised as one of the laboratories meeting regulatory requirements.

In April 2026, the Lecheng Medical Products Administration conducted on-site compliance inspections of 17 relevant laboratories in the zone, of which 8 laboratories passed. Qionghai Beike met the regulatory requirements on the strength of its solid technical system and rigorous quality management.

As an important participant in the biomedical new-technology field of the Lecheng Pilot Zone, Qionghai Beike has consistently built its laboratory platform to high standards, strictly following the relevant national and Hainan Province regulations and guidelines, and is committed to providing a compliant, stable and controllable preparation environment for the research and translation of cell-therapy products. Passing this compliance inspection is an authoritative recognition of Qionghai Beike’s hardware, software and quality-management strength, and marks a solid step forward in the company’s industrialisation of new biomedical technologies.

In future, Qionghai Beike will continue to draw on the policy advantages and industrial ecosystem of the Lecheng Pilot Zone, actively take part in the standardised development of new biomedical technologies, and advance their steady development on a safe, compliant and controllable track, contributing Beike’s strength to Lecheng’s goal of becoming a hub for biomedical innovation.